{"id":1841,"date":"2023-02-09T11:44:37","date_gmt":"2023-02-09T11:44:37","guid":{"rendered":"http:\/\/sh014.global.temp.domains\/~tojpyumy\/?page_id=1841"},"modified":"2023-03-06T10:10:03","modified_gmt":"2023-03-06T10:10:03","slug":"human-monoclonal-antibody-development","status":"publish","type":"page","link":"https:\/\/bioklone.com\/human-monoclonal-antibody-development\/","title":{"rendered":"Human monoclonal antibody development"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"1841\" class=\"elementor elementor-1841\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-647c9529 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no\" data-id=\"647c9529\" data-element_type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-wider\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-43fba4a\" data-id=\"43fba4a\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-8f31632 elementor-widget elementor-widget-image\" data-id=\"8f31632\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.21.0 - 08-05-2024 *\/\n.elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=\".svg\"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block}<\/style>\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"1003\" height=\"1024\" src=\"https:\/\/bioklone.com\/wp-content\/uploads\/2023\/02\/Service-3.-TC2a-mod-1-7-1003x1024.jpg\" class=\"attachment-large size-large wp-image-2071\" alt=\"\" srcset=\"https:\/\/bioklone.com\/wp-content\/uploads\/2023\/02\/Service-3.-TC2a-mod-1-7-1003x1024.jpg 1003w, https:\/\/bioklone.com\/wp-content\/uploads\/2023\/02\/Service-3.-TC2a-mod-1-7-294x300.jpg 294w, https:\/\/bioklone.com\/wp-content\/uploads\/2023\/02\/Service-3.-TC2a-mod-1-7-768x784.jpg 768w, https:\/\/bioklone.com\/wp-content\/uploads\/2023\/02\/Service-3.-TC2a-mod-1-7-1504x1536.jpg 1504w\" sizes=\"(max-width: 1003px) 100vw, 1003px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-d16f1c2\" data-id=\"d16f1c2\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6b29d1d4 elementor-widget elementor-widget-text-editor\" data-id=\"6b29d1d4\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.21.0 - 08-05-2024 *\/\n.elementor-widget-text-editor.elementor-drop-cap-view-stacked .elementor-drop-cap{background-color:#69727d;color:#fff}.elementor-widget-text-editor.elementor-drop-cap-view-framed .elementor-drop-cap{color:#69727d;border:3px solid;background-color:transparent}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap{margin-top:8px}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap-letter{width:1em;height:1em}.elementor-widget-text-editor .elementor-drop-cap{float:left;text-align:center;line-height:1;font-size:50px}.elementor-widget-text-editor .elementor-drop-cap-letter{display:inline-block}<\/style>\t\t\t\t<h4>Human monoclonal antibody development<\/h4>\n<b><i>\u201c30+ years\u2019 experience\u201d<\/i><\/b><br>\n<b><i>\u201cInnovative, scientific, interactive and customer-centric services\u201d<\/i><\/b>\n<p style=\"font-weight: 400; margin-top: 10px;\">Development of human monoclonal antibodies by EBV transformation of PBMCs or B cells from convalescent blood.<\/p>\n<b>In 2020-21, Bioklone Biotech Private Limited received funding under strategic funding for Covid-19 consortium under National Biopharma Mission for \u201cDevelopment of human monoclonal antibodies to SARS-CoV-2 from convalescent patient blood\u201d.<\/b>\n<br>\n<a href=\"https:\/\/birac.nic.in\/nbm\/cms\/page\/therapeutic-strategies-for-COVID\"><span style=\"font-weight: 400; color:#03448C;\">https:\/\/birac.nic.in\/nbm\/cms\/page\/therapeutic-strategies-for-COVID<\/span><\/a>\n<h4><strong>For more information, please <a href=\"https:\/\/bioklone.com\/contact-us\/\"style=\"color:#03448C;\" >contact us<\/a><\/strong><\/h4>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Human monoclonal antibody development \u201c30+ years\u2019 experience\u201d \u201cInnovative, scientific, interactive and customer-centric services\u201d Development of human monoclonal antibodies by EBV transformation of PBMCs or B cells from convalescent blood. In 2020-21, Bioklone Biotech Private Limited received funding under strategic funding for Covid-19 consortium under National Biopharma Mission for \u201cDevelopment of human monoclonal antibodies to SARS-CoV-2 &hellip;<\/p>\n<p class=\"read-more\"> <a class=\"\" href=\"https:\/\/bioklone.com\/human-monoclonal-antibody-development\/\"> <span class=\"screen-reader-text\">Human monoclonal antibody development<\/span> Read More &raquo;<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-global-header-display":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","footnotes":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Human monoclonal antibody development - Bioklone<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bioklone.com\/human-monoclonal-antibody-development\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Human monoclonal antibody development - Bioklone\" \/>\n<meta property=\"og:description\" content=\"Human monoclonal antibody development \u201c30+ years\u2019 experience\u201d \u201cInnovative, scientific, interactive and customer-centric services\u201d Development of human monoclonal antibodies by EBV transformation of PBMCs or B cells from convalescent blood. In 2020-21, Bioklone Biotech Private Limited received funding under strategic funding for Covid-19 consortium under National Biopharma Mission for \u201cDevelopment of human monoclonal antibodies to SARS-CoV-2 &hellip; Human monoclonal antibody development Read More &raquo;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bioklone.com\/human-monoclonal-antibody-development\/\" \/>\n<meta property=\"og:site_name\" content=\"Bioklone\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-06T10:10:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bioklone.com\/wp-content\/uploads\/2023\/02\/Service-3.-TC2a-mod-1-7-1003x1024.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bioklone.com\/human-monoclonal-antibody-development\/\",\"url\":\"https:\/\/bioklone.com\/human-monoclonal-antibody-development\/\",\"name\":\"Human monoclonal antibody development - Bioklone\",\"isPartOf\":{\"@id\":\"http:\/\/sh014.global.temp.domains\/~tojpyumy\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/bioklone.com\/human-monoclonal-antibody-development\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/bioklone.com\/human-monoclonal-antibody-development\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/bioklone.com\/wp-content\/uploads\/2023\/02\/Service-3.-TC2a-mod-1-7-1003x1024.jpg\",\"datePublished\":\"2023-02-09T11:44:37+00:00\",\"dateModified\":\"2023-03-06T10:10:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/bioklone.com\/human-monoclonal-antibody-development\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bioklone.com\/human-monoclonal-antibody-development\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/bioklone.com\/human-monoclonal-antibody-development\/#primaryimage\",\"url\":\"https:\/\/bioklone.com\/wp-content\/uploads\/2023\/02\/Service-3.-TC2a-mod-1-7-1003x1024.jpg\",\"contentUrl\":\"https:\/\/bioklone.com\/wp-content\/uploads\/2023\/02\/Service-3.-TC2a-mod-1-7-1003x1024.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bioklone.com\/human-monoclonal-antibody-development\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bioklone.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Human monoclonal antibody development\"}]},{\"@type\":\"WebSite\",\"@id\":\"http:\/\/sh014.global.temp.domains\/~tojpyumy\/#website\",\"url\":\"http:\/\/sh014.global.temp.domains\/~tojpyumy\/\",\"name\":\"Bioklone\",\"description\":\"\",\"publisher\":{\"@id\":\"http:\/\/sh014.global.temp.domains\/~tojpyumy\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\/\/sh014.global.temp.domains\/~tojpyumy\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"http:\/\/sh014.global.temp.domains\/~tojpyumy\/#organization\",\"name\":\"Bioklone\",\"url\":\"http:\/\/sh014.global.temp.domains\/~tojpyumy\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\/\/sh014.global.temp.domains\/~tojpyumy\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/bioklone.com\/wp-content\/uploads\/2023\/02\/logo-new.png\",\"contentUrl\":\"https:\/\/bioklone.com\/wp-content\/uploads\/2023\/02\/logo-new.png\",\"width\":371,\"height\":272,\"caption\":\"Bioklone\"},\"image\":{\"@id\":\"http:\/\/sh014.global.temp.domains\/~tojpyumy\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Human monoclonal antibody development - Bioklone","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bioklone.com\/human-monoclonal-antibody-development\/","og_locale":"en_US","og_type":"article","og_title":"Human monoclonal antibody development - Bioklone","og_description":"Human monoclonal antibody development \u201c30+ years\u2019 experience\u201d \u201cInnovative, scientific, interactive and customer-centric services\u201d Development of human monoclonal antibodies by EBV transformation of PBMCs or B cells from convalescent blood. In 2020-21, Bioklone Biotech Private Limited received funding under strategic funding for Covid-19 consortium under National Biopharma Mission for \u201cDevelopment of human monoclonal antibodies to SARS-CoV-2 &hellip; Human monoclonal antibody development Read More &raquo;","og_url":"https:\/\/bioklone.com\/human-monoclonal-antibody-development\/","og_site_name":"Bioklone","article_modified_time":"2023-03-06T10:10:03+00:00","og_image":[{"url":"https:\/\/bioklone.com\/wp-content\/uploads\/2023\/02\/Service-3.-TC2a-mod-1-7-1003x1024.jpg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/bioklone.com\/human-monoclonal-antibody-development\/","url":"https:\/\/bioklone.com\/human-monoclonal-antibody-development\/","name":"Human monoclonal antibody development - Bioklone","isPartOf":{"@id":"http:\/\/sh014.global.temp.domains\/~tojpyumy\/#website"},"primaryImageOfPage":{"@id":"https:\/\/bioklone.com\/human-monoclonal-antibody-development\/#primaryimage"},"image":{"@id":"https:\/\/bioklone.com\/human-monoclonal-antibody-development\/#primaryimage"},"thumbnailUrl":"https:\/\/bioklone.com\/wp-content\/uploads\/2023\/02\/Service-3.-TC2a-mod-1-7-1003x1024.jpg","datePublished":"2023-02-09T11:44:37+00:00","dateModified":"2023-03-06T10:10:03+00:00","breadcrumb":{"@id":"https:\/\/bioklone.com\/human-monoclonal-antibody-development\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bioklone.com\/human-monoclonal-antibody-development\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/bioklone.com\/human-monoclonal-antibody-development\/#primaryimage","url":"https:\/\/bioklone.com\/wp-content\/uploads\/2023\/02\/Service-3.-TC2a-mod-1-7-1003x1024.jpg","contentUrl":"https:\/\/bioklone.com\/wp-content\/uploads\/2023\/02\/Service-3.-TC2a-mod-1-7-1003x1024.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/bioklone.com\/human-monoclonal-antibody-development\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bioklone.com\/"},{"@type":"ListItem","position":2,"name":"Human monoclonal antibody development"}]},{"@type":"WebSite","@id":"http:\/\/sh014.global.temp.domains\/~tojpyumy\/#website","url":"http:\/\/sh014.global.temp.domains\/~tojpyumy\/","name":"Bioklone","description":"","publisher":{"@id":"http:\/\/sh014.global.temp.domains\/~tojpyumy\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/sh014.global.temp.domains\/~tojpyumy\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"http:\/\/sh014.global.temp.domains\/~tojpyumy\/#organization","name":"Bioklone","url":"http:\/\/sh014.global.temp.domains\/~tojpyumy\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/sh014.global.temp.domains\/~tojpyumy\/#\/schema\/logo\/image\/","url":"https:\/\/bioklone.com\/wp-content\/uploads\/2023\/02\/logo-new.png","contentUrl":"https:\/\/bioklone.com\/wp-content\/uploads\/2023\/02\/logo-new.png","width":371,"height":272,"caption":"Bioklone"},"image":{"@id":"http:\/\/sh014.global.temp.domains\/~tojpyumy\/#\/schema\/logo\/image\/"}}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/bioklone.com\/wp-json\/wp\/v2\/pages\/1841"}],"collection":[{"href":"https:\/\/bioklone.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/bioklone.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/bioklone.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bioklone.com\/wp-json\/wp\/v2\/comments?post=1841"}],"version-history":[{"count":20,"href":"https:\/\/bioklone.com\/wp-json\/wp\/v2\/pages\/1841\/revisions"}],"predecessor-version":[{"id":2804,"href":"https:\/\/bioklone.com\/wp-json\/wp\/v2\/pages\/1841\/revisions\/2804"}],"wp:attachment":[{"href":"https:\/\/bioklone.com\/wp-json\/wp\/v2\/media?parent=1841"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}